- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04264299
Comparative Study of Three Common Bile Duct Closure Techniques
Comparative Study of Three Common Bile Duct Closure Techniques After Choledocholithotomy: Safety and Efficacy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
At present, the commonest available options for CBD closure include repair over T-tube drain, primary closure, and repair after antegrade biliary stenting. All three methods present specific technical performance features, require different postoperative management protocols, and are charged with specific morbidity related to the procedure and therefore should not be considered the same procedure in the context of CBDE.
Repair over T-tube is the traditional surgical technique. It has many advantages as post-operative distal CBD decompression, trans-tubal cholangiography, and availability of retained CBD stones extraction. However, it has several potential complications up to 10% of patients. The most frequent complications are bile leakage, tract infection, T-tube dislodgement, electrolyte and nutritional disturbances, cholangitis, or acute renal failure from dehydration due to inadequate water ingestion. It also causes discomfort and persistent pain to the patient along with increased hospital admission and thus the economic burden to the country. Primary closure of CBD has been described in the literature to overcome these adverse consequences of the T-tube. However, it has many potential complications as a potential bile leak and CBD stricture, which may occur due to papillary edema and insufficient bile duct expansion. There are conflicting results regarding significant differences in the morbidity and mortality between primary closure and T-tube drainage. There is no conclusive evidence displaying whether primary closure is better or worse than T-tube drainage after CBD exploration.
Using a biliary stent in primary closure is an effective method to decrease the two complications, which can reduce biliary pressure without bile loss. Although there are some available drainage options after CBDE, a consensus on the optimal drainage is yet to be reached.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Qena
-
Sohag, Qena, Egypt, 83523
- Mohammed Ahmed Omar
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria
- CBD stones
- age from 20 to 80,
- CBD > 0.8 cm and < 2.5 cm,
- American Society of Anesthesiologists (ASA) grade I, II or III,
- agreement to randomization and complete the study requirement. Exclusion criteria
- acute suppurative cholangitis,
- acute biliary pancreatitis,
- biliary malignancy,
- biliary malformation,
- distal CBD stenosis and or obstruction,
- trans-cystic stone extraction,
- explorations followed by choledochojejunostomy and choledochoduodenostomy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: T tube drainage
Closure of common bile duct after choledocholithotomy over T tube
|
Primary closure of common bile duct
Closure of common bile duct over antegrade plastic biliary stent
|
|
Experimental: Primary closure
Primary closure of the common bile duct after choledocholithotomy
|
Closure of common bile duct over antegrade plastic biliary stent
closure of common bile duct over T tube
|
|
Experimental: Antegrade stenting
Closure of common bile duct over antegrade biliary plastic stent
|
Primary closure of common bile duct
closure of common bile duct over T tube
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative bile leak
Time Frame: 3rd to 7th postoperative day
|
The discharge of fluid via intra-abdominal drain or intra-abdominal fluid with bilirubin concentration at least 3 times the serum bilirubin concentration measured at the same time on or after the 3rd postoperative day, or as the need for radiologic or surgical intervention because of biliary collections.
|
3rd to 7th postoperative day
|
|
Post operative biliary stricture
Time Frame: 6 month
|
The segmental shrunken of CBD diameter and proximal dilatation by MRCP.
|
6 month
|
|
Recurrent biliary stones
Time Frame: 6 month
|
Common bile duct stone after 6 months of the procedure
|
6 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual analogue score
Time Frame: 3 days
|
the severity of postoperative pain.
from 0 (no pain) to 10 (maximum pain)
|
3 days
|
|
The number of patients need postoperative opioid
Time Frame: 3 days
|
The patients need of postoperative opioid (pethidine Hcl 50 mg)
|
3 days
|
|
Postoperative bilirubin level
Time Frame: 7 days
|
the rate of decreased bilirubin postoperatively
|
7 days
|
|
Hospital stays
Time Frame: 10 days
|
the number of days in hospital from the day of operation to the day of discharge
|
10 days
|
|
Drain-carried time
Time Frame: 20 days
|
the number of days before drain removal
|
20 days
|
|
Total cost of treatment
Time Frame: Through study completion, average 6 month
|
The cost of intervention and management of postoperative complications
|
Through study completion, average 6 month
|
|
Return to normal activity
Time Frame: 30 days
|
the number of days required for the patient to return to normal activity
|
30 days
|
|
Type of re-intervention
Time Frame: 6 month
|
the number of intervention required for each patient totally
|
6 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mohammed A. Omar, Ass. Prof., South Valley University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SVU 300
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Common Bile Duct Closure
-
Gujranwala medical college District Headquarters...CompletedCommon Bile Duct Diseases | Common Bile Duct Calculi | Common Bile Duct Stricture | Common Bile Duct Neoplasms | Common Bile Duct DilatationPakistan
-
Instituto Ecuatoriano de Enfermedades DigestivasUniversity of Sao Paulo; Universitair Ziekenhuis Brussel; The Methodist Hospital... and other collaboratorsCompletedCommon Bile Duct Neoplasms | Non-Neoplastic Bile Duct DisorderUnited States, Ecuador, Belgium, Brazil
-
Mohamed Ahmed Hassan AlyNot yet recruitingRecurrent Common Bile Duct StonesEgypt
-
Société Française d'Endoscopie DigestiveCompletedCholedocholithiasis | Large Common Bile Duct Stone
-
University of Sao Paulo General HospitalBoston Scientific CorporationUnknownCholedocholithiasis | Common Bile Duct GallstonesBrazil
-
Qilu Hospital of Shandong UniversityThe Affiliated Hospital of Qingdao University; Qingdao Municipal Hospital; Qianfoshan... and other collaboratorsRecruitingCholelithiasis Associated With Common Bile Duct StonesChina
-
Allium, Ltd.WithdrawnMalignant Obstruction of the Common Bile DuctIsrael
-
Asian Institute of Gastroenterology, IndiaRecruiting
-
National Liver Institute, EgyptCompleted
-
Università Vita-Salute San RaffaeleValduce Hospital; Istituti Ospitalieri di Cremona; Azienda Ospedaliera Universitaria... and other collaboratorsTerminated
Clinical Trials on Primary closure
-
University of LouisvilleCompleted
-
Ayub Teaching HospitalCompletedPeritonitis | Primary Closure | Delayed Primary ClosurePakistan
-
Konya City HospitalCompleted
-
University of MinnesotaCentre Hospitalier Universitaire VaudoisCompleted
-
Erasmus Medical CenterBaxter Healthcare Corporation; Aesculap AGCompletedIncisional Hernia OccurenceNetherlands, Austria, Germany
-
Eduardo Flores VillalbaCompletedSurgical Wound InfectionMexico
-
Assiut UniversityNot yet recruiting
-
Bkahtawar Amin Medical and Dental College MultanCompletedLaparotomy Closure After Abdominal SurgeryPakistan
-
Ruth Kaufmann, MDCompleted
-
Ayub Teaching HospitalCompleted